Zhuoran Gu
301 Middle Yan Chang Road
Shanghai, 200072, China
Shanghai, 200072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
ALOX5 mediates sunitinib resistance in renal cell carcinoma by reprogramming lipid metabolism through the p38/ERK/PPARα axis.
Journal: International immunopharmacology
Published: April 14, 2026
ADAMTS9-AS2 Disrupts Docetaxel-Resistance in Castration-Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 23, 2025
Correction: Zhang et al. An Integrated Approach Utilizing Single-Cell and Bulk RNA-Sequencing for the Identification of a Mitophagy-Associated Genes Signature: Implications for Prognostication and Therapeutic Stratification in Prostate Cancer. Biomedicines 2025, 13, 311.
Journal: Biomedicines
Published: September 01, 2025
Integrative molecular-radiopathomic characterization of AIRE-driven immune subtypes in bladder cancer.
Journal: NPJ digital medicine
Published: August 04, 2025
USP21/YBX1/HIF1-α promotes the progression of prostate cancer.
Journal: Journal of translational medicine
Published: July 21, 2025
Management of a nephrostomy tube misplacement into the inferior vena cava following PCNL.
Journal: Urology case reports
Published: March 10, 2025
Surgical treatment of giant seminal vesicle cyst with ureteral compression: a case report.
Journal: Frontiers in surgery
Published: September 28, 2024
The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression.
Journal: MedComm
Published: July 19, 2024
Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8+ T cell activity in prostate cancer.
Journal: Molecular biomedicine
Published: April 26, 2024
SOX7 inhibits the malignant progression of bladder cancer via the DNMT3B/CYGB axis.
Journal: Molecular biomedicine
Published: March 27, 2024
CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer.
Journal: Experimental & molecular medicine
Published: February 19, 2024
Last Updated: 09/26/2026